IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling strategies.
Saved in:
| Title: | IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling strategies. |
|---|---|
| Authors: | Ahmad A; University of Manchester, United Kingdom. Electronic address: amais.ahmed@manchester.ac.uk., Pepin X; AstraZeneca, United Kingdom., Aarons L; University of Manchester, United Kingdom., Wang Y; University of Manchester, United Kingdom., Darwich AS; Royal Institute of Technology, Stockholm, Sweden., Wood JM; AstraZeneca, United Kingdom., Tannergren C; AstraZeneca, United Kingdom., Karlsson E; AstraZeneca, United Kingdom., Patterson C; AstraZeneca, United Kingdom., Thörn H; AstraZeneca, United Kingdom., Ruston L; AstraZeneca, United Kingdom., Mattinson A; AstraZeneca, United Kingdom., Carlert S; AstraZeneca, United Kingdom., Berg S; AstraZeneca, United Kingdom., Murphy D; AstraZeneca, United Kingdom., Engman H; AstraZeneca, United Kingdom., Laru J; AstraZeneca, United Kingdom., Barker R; AstraZeneca, United Kingdom., Flanagan T; AstraZeneca, United Kingdom., Abrahamsson B; AstraZeneca, United Kingdom., Budhdeo S; AstraZeneca, United Kingdom., Franek F; AstraZeneca, United Kingdom., Moir A; AstraZeneca, United Kingdom., Hanisch G; AstraZeneca, United Kingdom., Pathak SM; Certara, Simcyp Division, United Kingdom., Turner D; Certara, Simcyp Division, United Kingdom., Jamei M; Certara, Simcyp Division, United Kingdom., Brown J; Bristol-Myers Squibb, United Kingdom., Good D; Bristol-Myers Squibb, United Kingdom., Vaidhyanathan S; Bristol-Myers Squibb, United Kingdom., Jackson C; Bristol-Myers Squibb, United Kingdom., Nicolas O; Sanofi, United States., Beilles S; Sanofi, United States., Nguefack JF; Sanofi, United States., Louit G; Sanofi, United States., Henrion L; Sanofi, United States., Ollier C; Sanofi, United States., Boulu L; Sanofi, United States., Xu C; Sanofi, United States., Heimbach T; Novartis, United States., Ren X; Novartis, United States., Lin W; Novartis, United States., Nguyen-Trung AT; Novartis, United States., Zhang J; Novartis, United States., He H; Novartis, United States., Wu F; Novartis, United States., Bolger MB; Simulation Plus, Inc., United States., Mullin JM; Simulation Plus, Inc., United States., van Osdol B; Simulation Plus, Inc., United States., Szeto K; Simulation Plus, Inc., United States., Korjamo T; Orion Pharma, Finland., Pappinen S; Orion Pharma, Finland., Tuunainen J; Orion Pharma, Finland., Zhu W; Merck Research Laboratories, Merck & Co., United States., Xia B; Merck Research Laboratories, Merck & Co., United States., Daublain P; Merck Research Laboratories, Merck & Co., United States., Wong S; Pfizer, United States., Varma MVS; Pfizer, United States., Modi S; Pfizer, United States., Schäfer KJ; Boehringer-ingelheim, Germany., Schmid K; Boehringer-ingelheim, Germany., Lloyd R; GlaxoSmithKline, United Kingdom., Patel A; GlaxoSmithKline, United Kingdom., Tistaert C; Janssen, Belgium., Bevernage J; Janssen, Belgium., Nguyen MA; Johannes Gutenberg University of Mainz, Germany., Lindley D; AbbVie, Germany., Carr R; AbbVie, Germany., Rostami-Hodjegan A; University of Manchester, United Kingdom; Certara, Simcyp Division, United Kingdom. |
| Source: | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2020 Nov; Vol. 156, pp. 50-63. Date of Electronic Publication: 2020 Aug 14. |
| Publication Type: | Comparative Study; Evaluation Study; Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9109778 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3441 (Electronic) Linking ISSN: 09396411 NLM ISO Abbreviation: Eur J Pharm Biopharm Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32805361 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling strategies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ahmad+A%22">Ahmad A</searchLink>; University of Manchester, United Kingdom. Electronic address: amais.ahmed@manchester.ac.uk.<br /><searchLink fieldCode="AU" term="%22Pepin+X%22">Pepin X</searchLink>; AstraZeneca, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Aarons+L%22">Aarons L</searchLink>; University of Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; University of Manchester, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Darwich+AS%22">Darwich AS</searchLink>; Royal Institute of Technology, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Wood+JM%22">Wood JM</searchLink>; AstraZeneca, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Tannergren+C%22">Tannergren C</searchLink>; AstraZeneca, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Karlsson+E%22">Karlsson E</searchLink>; AstraZeneca, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Patterson+C%22">Patterson C</searchLink>; AstraZeneca, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Thörn+H%22">Thörn H</searchLink>; AstraZeneca, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ruston+L%22">Ruston L</searchLink>; AstraZeneca, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Mattinson+A%22">Mattinson A</searchLink>; AstraZeneca, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Carlert+S%22">Carlert S</searchLink>; AstraZeneca, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Berg+S%22">Berg S</searchLink>; AstraZeneca, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Murphy+D%22">Murphy D</searchLink>; AstraZeneca, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Engman+H%22">Engman H</searchLink>; AstraZeneca, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Laru+J%22">Laru J</searchLink>; AstraZeneca, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Barker+R%22">Barker R</searchLink>; AstraZeneca, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Flanagan+T%22">Flanagan T</searchLink>; AstraZeneca, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Abrahamsson+B%22">Abrahamsson B</searchLink>; AstraZeneca, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Budhdeo+S%22">Budhdeo S</searchLink>; AstraZeneca, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Franek+F%22">Franek F</searchLink>; AstraZeneca, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Moir+A%22">Moir A</searchLink>; AstraZeneca, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hanisch+G%22">Hanisch G</searchLink>; AstraZeneca, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Pathak+SM%22">Pathak SM</searchLink>; Certara, Simcyp Division, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Turner+D%22">Turner D</searchLink>; Certara, Simcyp Division, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Jamei+M%22">Jamei M</searchLink>; Certara, Simcyp Division, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Brown+J%22">Brown J</searchLink>; Bristol-Myers Squibb, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Good+D%22">Good D</searchLink>; Bristol-Myers Squibb, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Vaidhyanathan+S%22">Vaidhyanathan S</searchLink>; Bristol-Myers Squibb, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Jackson+C%22">Jackson C</searchLink>; Bristol-Myers Squibb, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Nicolas+O%22">Nicolas O</searchLink>; Sanofi, United States.<br /><searchLink fieldCode="AU" term="%22Beilles+S%22">Beilles S</searchLink>; Sanofi, United States.<br /><searchLink fieldCode="AU" term="%22Nguefack+JF%22">Nguefack JF</searchLink>; Sanofi, United States.<br /><searchLink fieldCode="AU" term="%22Louit+G%22">Louit G</searchLink>; Sanofi, United States.<br /><searchLink fieldCode="AU" term="%22Henrion+L%22">Henrion L</searchLink>; Sanofi, United States.<br /><searchLink fieldCode="AU" term="%22Ollier+C%22">Ollier C</searchLink>; Sanofi, United States.<br /><searchLink fieldCode="AU" term="%22Boulu+L%22">Boulu L</searchLink>; Sanofi, United States.<br /><searchLink fieldCode="AU" term="%22Xu+C%22">Xu C</searchLink>; Sanofi, United States.<br /><searchLink fieldCode="AU" term="%22Heimbach+T%22">Heimbach T</searchLink>; Novartis, United States.<br /><searchLink fieldCode="AU" term="%22Ren+X%22">Ren X</searchLink>; Novartis, United States.<br /><searchLink fieldCode="AU" term="%22Lin+W%22">Lin W</searchLink>; Novartis, United States.<br /><searchLink fieldCode="AU" term="%22Nguyen-Trung+AT%22">Nguyen-Trung AT</searchLink>; Novartis, United States.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Novartis, United States.<br /><searchLink fieldCode="AU" term="%22He+H%22">He H</searchLink>; Novartis, United States.<br /><searchLink fieldCode="AU" term="%22Wu+F%22">Wu F</searchLink>; Novartis, United States.<br /><searchLink fieldCode="AU" term="%22Bolger+MB%22">Bolger MB</searchLink>; Simulation Plus, Inc., United States.<br /><searchLink fieldCode="AU" term="%22Mullin+JM%22">Mullin JM</searchLink>; Simulation Plus, Inc., United States.<br /><searchLink fieldCode="AU" term="%22van+Osdol+B%22">van Osdol B</searchLink>; Simulation Plus, Inc., United States.<br /><searchLink fieldCode="AU" term="%22Szeto+K%22">Szeto K</searchLink>; Simulation Plus, Inc., United States.<br /><searchLink fieldCode="AU" term="%22Korjamo+T%22">Korjamo T</searchLink>; Orion Pharma, Finland.<br /><searchLink fieldCode="AU" term="%22Pappinen+S%22">Pappinen S</searchLink>; Orion Pharma, Finland.<br /><searchLink fieldCode="AU" term="%22Tuunainen+J%22">Tuunainen J</searchLink>; Orion Pharma, Finland.<br /><searchLink fieldCode="AU" term="%22Zhu+W%22">Zhu W</searchLink>; Merck Research Laboratories, Merck & Co., United States.<br /><searchLink fieldCode="AU" term="%22Xia+B%22">Xia B</searchLink>; Merck Research Laboratories, Merck & Co., United States.<br /><searchLink fieldCode="AU" term="%22Daublain+P%22">Daublain P</searchLink>; Merck Research Laboratories, Merck & Co., United States.<br /><searchLink fieldCode="AU" term="%22Wong+S%22">Wong S</searchLink>; Pfizer, United States.<br /><searchLink fieldCode="AU" term="%22Varma+MVS%22">Varma MVS</searchLink>; Pfizer, United States.<br /><searchLink fieldCode="AU" term="%22Modi+S%22">Modi S</searchLink>; Pfizer, United States.<br /><searchLink fieldCode="AU" term="%22Schäfer+KJ%22">Schäfer KJ</searchLink>; Boehringer-ingelheim, Germany.<br /><searchLink fieldCode="AU" term="%22Schmid+K%22">Schmid K</searchLink>; Boehringer-ingelheim, Germany.<br /><searchLink fieldCode="AU" term="%22Lloyd+R%22">Lloyd R</searchLink>; GlaxoSmithKline, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Patel+A%22">Patel A</searchLink>; GlaxoSmithKline, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Tistaert+C%22">Tistaert C</searchLink>; Janssen, Belgium.<br /><searchLink fieldCode="AU" term="%22Bevernage+J%22">Bevernage J</searchLink>; Janssen, Belgium.<br /><searchLink fieldCode="AU" term="%22Nguyen+MA%22">Nguyen MA</searchLink>; Johannes Gutenberg University of Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Lindley+D%22">Lindley D</searchLink>; AbbVie, Germany.<br /><searchLink fieldCode="AU" term="%22Carr+R%22">Carr R</searchLink>; AbbVie, Germany.<br /><searchLink fieldCode="AU" term="%22Rostami-Hodjegan+A%22">Rostami-Hodjegan A</searchLink>; University of Manchester, United Kingdom; Certara, Simcyp Division, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229109778%22">European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V</searchLink> [Eur J Pharm Biopharm] 2020 Nov; Vol. 156, pp. 50-63. <i>Date of Electronic Publication: </i>2020 Aug 14. – Name: TypePub Label: Publication Type Group: TypPub Data: Comparative Study; Evaluation Study; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9109778 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-3441 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209396411%22">09396411 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Pharm Biopharm <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32805361 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ejpb.2020.08.006 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 50 Titles: – TitleFull: IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling strategies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ahmad A – PersonEntity: Name: NameFull: Pepin X – PersonEntity: Name: NameFull: Aarons L – PersonEntity: Name: NameFull: Wang Y – PersonEntity: Name: NameFull: Darwich AS – PersonEntity: Name: NameFull: Wood JM – PersonEntity: Name: NameFull: Tannergren C – PersonEntity: Name: NameFull: Karlsson E – PersonEntity: Name: NameFull: Patterson C – PersonEntity: Name: NameFull: Thörn H – PersonEntity: Name: NameFull: Ruston L – PersonEntity: Name: NameFull: Mattinson A – PersonEntity: Name: NameFull: Carlert S – PersonEntity: Name: NameFull: Berg S – PersonEntity: Name: NameFull: Murphy D – PersonEntity: Name: NameFull: Engman H – PersonEntity: Name: NameFull: Laru J – PersonEntity: Name: NameFull: Barker R – PersonEntity: Name: NameFull: Flanagan T – PersonEntity: Name: NameFull: Abrahamsson B – PersonEntity: Name: NameFull: Budhdeo S – PersonEntity: Name: NameFull: Franek F – PersonEntity: Name: NameFull: Moir A – PersonEntity: Name: NameFull: Hanisch G – PersonEntity: Name: NameFull: Pathak SM – PersonEntity: Name: NameFull: Turner D – PersonEntity: Name: NameFull: Jamei M – PersonEntity: Name: NameFull: Brown J – PersonEntity: Name: NameFull: Good D – PersonEntity: Name: NameFull: Vaidhyanathan S – PersonEntity: Name: NameFull: Jackson C – PersonEntity: Name: NameFull: Nicolas O – PersonEntity: Name: NameFull: Beilles S – PersonEntity: Name: NameFull: Nguefack JF – PersonEntity: Name: NameFull: Louit G – PersonEntity: Name: NameFull: Henrion L – PersonEntity: Name: NameFull: Ollier C – PersonEntity: Name: NameFull: Boulu L – PersonEntity: Name: NameFull: Xu C – PersonEntity: Name: NameFull: Heimbach T – PersonEntity: Name: NameFull: Ren X – PersonEntity: Name: NameFull: Lin W – PersonEntity: Name: NameFull: Nguyen-Trung AT – PersonEntity: Name: NameFull: Zhang J – PersonEntity: Name: NameFull: He H – PersonEntity: Name: NameFull: Wu F – PersonEntity: Name: NameFull: Bolger MB – PersonEntity: Name: NameFull: Mullin JM – PersonEntity: Name: NameFull: van Osdol B – PersonEntity: Name: NameFull: Szeto K – PersonEntity: Name: NameFull: Korjamo T – PersonEntity: Name: NameFull: Pappinen S – PersonEntity: Name: NameFull: Tuunainen J – PersonEntity: Name: NameFull: Zhu W – PersonEntity: Name: NameFull: Xia B – PersonEntity: Name: NameFull: Daublain P – PersonEntity: Name: NameFull: Wong S – PersonEntity: Name: NameFull: Varma MVS – PersonEntity: Name: NameFull: Modi S – PersonEntity: Name: NameFull: Schäfer KJ – PersonEntity: Name: NameFull: Schmid K – PersonEntity: Name: NameFull: Lloyd R – PersonEntity: Name: NameFull: Patel A – PersonEntity: Name: NameFull: Tistaert C – PersonEntity: Name: NameFull: Bevernage J – PersonEntity: Name: NameFull: Nguyen MA – PersonEntity: Name: NameFull: Lindley D – PersonEntity: Name: NameFull: Carr R – PersonEntity: Name: NameFull: Rostami-Hodjegan A IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2020 Nov Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1873-3441 Numbering: – Type: volume Value: 156 Titles: – TitleFull: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V Type: main |
| ResultId | 1 |
